Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Kyodo News via Getty Images

Next week, Japanese Prime Minister Shinzo Abe visits President Trump at Mar-a-Lago on the heels of a big pivot from the White House as the president directed his top advisers to re-examine the Trans-Pacific Partnership.

The big picture: Trump seeks close cooperation with Japan on resolving the North Korean nuclear threat, but he's alienating Tokyo with tariffs. Both issues are on the table as the two leaders meet on April 17th and 18th.

  1. Reconsidering TPP: The Japanese government has expressed its willingness to welcome the U.S. back to the TPP, but is proceeding with caution. Trump will take a close look at reforming bilateral or multilateral trade relationships with TPP members, but "there would have to be changes" to the deal for him to rejoin, a senior White House official said.
  2. Dealing with North Korea: Trump will seek advice from Abe on how to approach a summit with Kim Jong-un, per the senior official. A Japanese diplomat told Axios that Abe hopes to remind the president of his top policy priority which is to secure the U.S.'s help in rescuing the Japanese abductees in North Korea, some of whom have been in Pyongyang for over 40 years.
  3. Trump's steel and aluminum tariffs: The Japanese were alarmed when they were not exempted from the president's tariffs in March, and it's an issue that'll likely come up in Florida next week. The official said Trump "has left open an avenue" for Japan, and other U.S. allies, to petition for exemption.
  4. Chinese influence: China continues to pose a security threat for Japan with its military presence in the South China Sea. As the leaders meet, "naturally the issue of freedom of navigation in the South China Sea will come up ... It is a matter of international concern," the official said.

Go deeper: How the U.S. has interfered with Japan's plan to counter China

Go deeper

5 mins ago - Podcasts

Bob Nelsen on AstraZeneca and his plan to revolutionize biotech

AstraZeneca and the University of Oxford on Monday reported promising efficacy data for their COVID-19 vaccine, which has less stringent storage requirements than the Pfizer and Moderna vaccines and may be distributed earlier in developing countries.

Axios Re:Cap digs into the state of vaccine and therapeutics manufacturing with Bob Nelsen, a successful biotech investor who on Monday launched Resilience, a giant new pharma production platform that he believes will prepare America for its next major health challenges.

Ben Geman, author of Generate
Updated 12 mins ago - Energy & Environment

Unpacking Joe Biden's decision to tap John Kerry as his climate envoy

Photo: Pablo Blazquez Dominguez/Getty Images

President-elect Joe Biden is naming former Secretary of State John Kerry as a special presidential envoy for climate change.

Why it matters: The transition team's announcement sought to show that it will be an influential role, noting that Kerry — a former Massachusetts senator and the Democrats' 2004 presidential nominee — will be on the National Security Council.

Dave Lawler, author of World
2 hours ago - World

Oxford and AstraZeneca's vaccine won't just go to rich countries

Waiting, in New Delhi. Photo: Jewel Samad/AFP via Getty Images

While the 95% efficacy rates for the Moderna and Pfizer/BioNTech vaccines are great news for the U.S. and Europe, Monday's announcement from Oxford and AstraZeneca may be far more significant for the rest of the world.

Why it matters: Oxford and AstraZeneca plan to distribute their vaccine at cost (around $3-4 per dose), and have already committed to providing over 1 billion doses to the developing world. The price tags are higher for the Pfizer ($20) and Moderna ($32-37) vaccines.